Tien-Sheng Tseng

8PUBLICATIONS
1CO-AUTHORS
Molecular targetsPharmacogenomicsBiologically active moleculesGene and molecular therapyCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 04, 2026
Alpha-Lipoic Acid Inhibits IFN-γ-Induced PD-L1 Expression in Prostate Cancer Cells and Enhances T-Cell-Mediated Anti-Tumor Cytotoxicity.

|Feb 02, 2026
Pharmacophore-Based Identification and Molecular Characterization of Potent Neprilysin Inhibitors: Biochemical and Therapeutic Implications for Cardiovascular Diseases.

Chung-Ting Kuo, Yi-Chen Wu, Ji-Min Li

|Sep 17, 2025
Discovery and characterization of novel hematopoietic prostaglandin D synthase inhibitors from traditional Chinese medicine: the bioactive potential of dihydroberberine in treatments of Duchenne muscular dystrophy and inflammation-related diseases.

Cheng-Han Li, Min-Che Tung, Cheng-Kuan Tsai

|Jul 30, 2024
Combatting Antibiotic-Resistant Staphylococcus aureus: Discovery of TST1N-224, a Potent Inhibitor Targeting Response Regulator VraRC, through Pharmacophore-Based Screening and Molecular Characterizations.

Ying-Chu Hsu, Ching-Hui Liu, Yi-Chen Wu

|Nov 23, 2022
Pharmacophore-driven identification of human glutaminyl cyclase inhibitors from foods, plants and herbs unveils the bioactive property and potential of Azaleatin in the treatment of Alzheimer's disease.

Keng-Chang Tsai, Yi-Xuan Zhang, Hsiang-Yun Kao

|May 06, 2022
Characterization of the structure-function relationship of a novel salt-resistant antimicrobial peptide, RR12.

Ping-Sheng Wu, Shu-Jung Lai, Kit-Man Fung

Pageof 2

Frequent Collaborators

1 joint publications

Zhang-Min Lin